inclusion criteria: age equal to or above 18 years male or female gender in case of women, unwillingness to remain pregnant during the study period. written informed consent provided by the patient. for subjects without decision-making capacity, informed consent must be obtained from a legally designated representative following the national legislation in the member state where the trial is planned. confirmed infection by sars-cov-2 virus findings in chest-x-ray or in chest computed tomography compatible with lower respiratory tract infection need for hospitalization for covid-19. the need for hospitalization is defined by the attending physician taking into consideration clinical presentation, requirement for supportive care, potential risk factors for severe disease, and conditions at home, including the presence of vulnerable persons in the household. plasma supar ≥6ng/ml

inclusion criteria: age equal to or above 18 years male or female gender in case of women, unwillingness to remain pregnant during the study period. written informed consent provided by the patient. for subjects without decision-making capacity, informed consent must be obtained from a legally designated representative following the national legislation in the member state where the trial is planned. confirmed infection by sars-cov-2 virus findings in chest-x-ray or in chest computed tomography compatible with lower respiratory tract infection need for hospitalization for covid-19. the need for hospitalization is defined by the attending physician taking into consideration clinical presentation, requirement for supportive care, potential risk factors for severe disease, and conditions at home, including the presence of vulnerable persons in the household. plasma supar ≥6ng/ml

inclusion criteria: 1. age equal to or above 18 years 2. male or female gender 3. in case of women, unwillingness to remain pregnant during the study period. 4. written informed consent provided by the patient. for subjects without decision-making capacity, informed consent must be obtained from a legally designated representative following the national legislation in the member state where the trial is planned. 5. confirmed infection by sars-cov-2 virus 6. findings in chest-x-ray or in chest computed tomography compatible with lower respiratory tract infection 7. need for hospitalization for covid-19. the need for hospitalization is defined by the attending physician taking into consideration clinical presentation, requirement for supportive care, potential risk factors for severe disease, and conditions at home, including the presence of vulnerable persons in the household. 8. plasma supar ≥6ng/ml

inclusion criteria: 1. age equal to or above 18 years 2. male or female gender 3. in case of women, unwillingness to remain pregnant during the study period. 4. written informed consent provided by the patient. for subjects without decision-making capacity, informed consent must be obtained from a legally designated representative following the national legislation in the member state where the trial is planned. 5. confirmed infection by sars-cov-2 virus 6. findings in chest-x-ray or in chest computed tomography compatible with lower respiratory tract infection 7. need for hospitalization for covid-19. the need for hospitalization is defined by the attending physician taking into consideration clinical presentation, requirement for supportive care, potential risk factors for severe disease, and conditions at home, including the presence of vulnerable persons in the household. 8. plasma supar ≥6ng/ml